| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Psa5g3183 | ATGAGTGAGGATCTGAAGAAAACTGGTTCTGTTGGCCATGAGAAAATGTCACAAGAGCAACAGGCAAAGATCATTGAGGTGAGAAAGCTGATAGGAATATTATCAGAAAAGGAAACTGTGTATTGTACTGATGCAACCATTTCAAGGTACTTAAAATCGCAGAATTGGAATGTCAAGAAAGCGTCTCAAATGTTGAAGCAAAGCCTGAAATGGAGACGGGAGTACAAACCCGAAGAGATTCGCTGGGACGAGGTTTCTAATGAAGCAGAGATAGGGAAAATGTATAGAGCAAATTATTGTGACAAGCATGGAAGGCCGGTGATTATAATGAGAACAGATCGCGAGAATTCGAAGTCGTTGAAAGAAGAGATTAAGCATTTTGTTTACTGCATGGAGAATGCAGTTTTAAATCTACCACCTCTCCAGGAACAGGTGGTCTGGCTTGTTGATTTTCATGGCTTCAATTTATCAAATGTATCGTTCAAGATAACACGCGAAATTAGCCATATATTACAAAAGTACTATCCACAGCGCCTCGGATTGGCAATCATGTATGATGCACCTGGGATTTTCCAGCCATTCTTCGCGATGGTAAAGGTTCTGCTTGAGTCTGAGAGTTATAAAAAGGTAAAGTTTGTTTATTCTAACGACCAAAACACAAAGAAGATTATGGAGGGTTTGTTCGATATGGATCAACTTGAACCTGCATTTGGTGGGAACAACGACACGGAATTTGACATGAATAAATATGCTAAGAGAATGAAAGAGGAAGATAACAAGATGCACTCGTTATGGACACGGACAAACTCGCTATCATTGGTCTCGCGCAATATTCCTTCTTCTGATTCAACTGGGTCAGAAGCAGATTCTGATGCTTCCAACAATGAGAAAACACTCGGTTCCTCTATTCCTAACCCTGAGAAATCACTTGAAGTATGA | 939 | 0.4026 | MSEDLKKTGSVGHEKMSQEQQAKIIEVRKLIGILSEKETVYCTDATISRYLKSQNWNVKKASQMLKQSLKWRREYKPEEIRWDEVSNEAEIGKMYRANYCDKHGRPVIIMRTDRENSKSLKEEIKHFVYCMENAVLNLPPLQEQVVWLVDFHGFNLSNVSFKITREISHILQKYYPQRLGLAIMYDAPGIFQPFFAMVKVLLESESYKKVKFVYSNDQNTKKIMEGLFDMDQLEPAFGGNNDTEFDMNKYAKRMKEEDNKMHSLWTRTNSLSLVSRNIPSSDSTGSEADSDASNNEKTLGSSIPNPEKSLEV* | 313 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Psa5g3183 | 312 | MobiDBLite | consensus disorder prediction | 276 | 312 | - | - | |
| Psa5g3183 | 312 | ProSiteProfiles | CRAL-TRIO lipid binding domain profile. | 82 | 245 | IPR001251 | - | |
| Psa5g3183 | 312 | Pfam | CRAL/TRIO domain | 97 | 239 | IPR001251 | - | |
| Psa5g3183 | 312 | SUPERFAMILY | CRAL/TRIO domain | 82 | 260 | IPR036865 | - | |
| Psa5g3183 | 312 | MobiDBLite | consensus disorder prediction | 276 | 305 | - | - | |
| Psa5g3183 | 312 | PANTHER | GH16843P | 1 | 303 | - | - | |
| Psa5g3183 | 312 | Pfam | CRAL/TRIO, N-terminal domain | 21 | 66 | IPR011074 | - | |
| Psa5g3183 | 312 | PANTHER | CRAL-TRIO LIPID BINDING DOMAIN, CRAL/TRIO DOMAIN-CONTAINING PROTEIN-RELATED | 1 | 303 | - | - | |
| Psa5g3183 | 312 | SUPERFAMILY | CRAL/TRIO N-terminal domain | 15 | 84 | IPR036273 | - | |
| Psa5g3183 | 312 | CDD | SEC14 | 90 | 240 | IPR001251 | - | |
| Psa5g3183 | 312 | Gene3D | - | 2 | 276 | IPR036865 | - | |
| Psa5g3183 | 312 | SMART | sec14_4 | 88 | 242 | IPR001251 | - |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Psa5g3183 | Psa-Chr5 | 248062211 | 248064884 | Dispersed/Transposed |
| Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
|---|---|---|---|---|---|---|---|---|
| Psa5g3183 | 47 | 210 | Acyl Lipid Metabolism Gene Families | AT5G47730 | 26.984 | 4.52e-07 | 48.9 |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Psa5g3183 | - | - | cam:105852179 | 466.848 |